SG11201407505XA - Aptamer-based multiplexed assays - Google Patents

Aptamer-based multiplexed assays

Info

Publication number
SG11201407505XA
SG11201407505XA SG11201407505XA SG11201407505XA SG11201407505XA SG 11201407505X A SG11201407505X A SG 11201407505XA SG 11201407505X A SG11201407505X A SG 11201407505XA SG 11201407505X A SG11201407505X A SG 11201407505XA SG 11201407505X A SG11201407505X A SG 11201407505XA
Authority
SG
Singapore
Prior art keywords
aptamer
international
target
boulder
pct
Prior art date
Application number
SG11201407505XA
Other languages
English (en)
Inventor
Glenn Sanders
Stephan Kraemer
Evaldas Katilius
Original Assignee
Somalogic Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Somalogic Inc filed Critical Somalogic Inc
Publication of SG11201407505XA publication Critical patent/SG11201407505XA/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54393—Improving reaction conditions or stability, e.g. by coating or irradiation of surface, by reduction of non-specific binding, by promotion of specific binding
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6804—Nucleic acid analysis using immunogens
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
    • C12Q1/6813—Hybridisation assays
    • C12Q1/6834—Enzymatic or biochemical coupling of nucleic acids to a solid phase
    • C12Q1/6837—Enzymatic or biochemical coupling of nucleic acids to a solid phase using probe arrays or probe chips
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/5308—Immunoassay; Biospecific binding assay; Materials therefor for analytes not provided for elsewhere, e.g. nucleic acids, uric acid, worms, mites
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
    • G01N33/54306—Solid-phase reaction mechanisms
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6803—General methods of protein analysis not limited to specific proteins or families of proteins
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2525/00—Reactions involving modified oligonucleotides, nucleic acids, or nucleotides
    • C12Q2525/10—Modifications characterised by
    • C12Q2525/205—Aptamer
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q2563/00—Nucleic acid detection characterized by the use of physical, structural and functional properties
    • C12Q2563/107—Nucleic acid detection characterized by the use of physical, structural and functional properties fluorescence
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2570/00—Omics, e.g. proteomics, glycomics or lipidomics; Methods of analysis focusing on the entire complement of classes of biological molecules or subsets thereof, i.e. focusing on proteomes, glycomes or lipidomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • Microbiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • General Physics & Mathematics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • General Engineering & Computer Science (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Computational Biology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
SG11201407505XA 2012-06-07 2013-06-07 Aptamer-based multiplexed assays SG11201407505XA (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201261656956P 2012-06-07 2012-06-07
PCT/US2013/044792 WO2013185078A1 (en) 2012-06-07 2013-06-07 Aptamer-based multiplexed assays

Publications (1)

Publication Number Publication Date
SG11201407505XA true SG11201407505XA (en) 2014-12-30

Family

ID=49712701

Family Applications (2)

Application Number Title Priority Date Filing Date
SG10201701361WA SG10201701361WA (en) 2012-06-07 2013-06-07 Aptamer-based multiplexed assays
SG11201407505XA SG11201407505XA (en) 2012-06-07 2013-06-07 Aptamer-based multiplexed assays

Family Applications Before (1)

Application Number Title Priority Date Filing Date
SG10201701361WA SG10201701361WA (en) 2012-06-07 2013-06-07 Aptamer-based multiplexed assays

Country Status (22)

Country Link
US (4) US20150141259A1 (es)
EP (1) EP2859121B1 (es)
JP (1) JP6298456B2 (es)
KR (1) KR102088381B1 (es)
CN (2) CN108614102A (es)
AU (1) AU2013271401B2 (es)
BR (1) BR112014030298B1 (es)
CA (1) CA2873099C (es)
CY (1) CY1118748T1 (es)
ES (1) ES2617226T3 (es)
HK (1) HK1204341A1 (es)
HR (1) HRP20170296T1 (es)
IL (1) IL235588B (es)
IN (1) IN2014KN02647A (es)
MX (1) MX356413B (es)
MY (1) MY170164A (es)
NZ (1) NZ701824A (es)
PH (1) PH12014502581A1 (es)
RU (1) RU2666989C2 (es)
SG (2) SG10201701361WA (es)
WO (1) WO2013185078A1 (es)
ZA (1) ZA201408409B (es)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20110136099A1 (en) 2007-01-16 2011-06-09 Somalogic, Inc. Multiplexed Analyses of Test Samples
US8975026B2 (en) 2007-01-16 2015-03-10 Somalogic, Inc. Method for generating aptamers with improved off-rates
US7947447B2 (en) 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
US20160312265A1 (en) * 2014-01-14 2016-10-27 Aptitude Medical Systems, Inc. Use of nucleic acid agents for ultra-sensitive digital detection and quantification of target molecules
WO2015126769A1 (en) * 2014-02-18 2015-08-27 Somalogic, Inc. Compositions and methods for detecting microorganisms
US10890581B2 (en) * 2014-05-23 2021-01-12 Firefly Bioworks, Inc. Substrate-mediated reactors for bioassays
GB2528643A (en) * 2014-07-08 2016-02-03 Adc Biotechnology Ltd Method of synthesising ADCs
KR102003589B1 (ko) * 2016-03-03 2019-07-24 성균관대학교산학협력단 생화학 분자 검출센서 및 다파장 형광을 이용한 생화학 분자 검출방법
CN105779609A (zh) * 2016-04-15 2016-07-20 上海伊丽萨生物科技有限公司 一种超敏免疫检测方法
WO2018071813A1 (en) * 2016-10-13 2018-04-19 Laboratory Corporation Of America Holdings Devices and methods to reduce interfering compounds in biological samples
US20190317082A1 (en) * 2018-04-13 2019-10-17 Fluidigm Canada Inc. Stabilized cell acquisition for elemental analysis
SG11202012472TA (en) * 2018-06-22 2021-01-28 Somalogic Inc Improved proteomic multiplex assays
US11181501B2 (en) 2018-09-11 2021-11-23 City University Of Hong Kong Method and an apparatus for determining a presence or an amount of a polyamine or its derivative in a sample
LU101073B1 (en) * 2018-12-21 2020-06-24 Luxembourg Inst Science & Tech List Dna aptamers specific of adenovirus types
KR102177672B1 (ko) * 2019-02-01 2020-11-12 주식회사 압타머사이언스 압타머를 이용한 다중(multiplex) PCR 방법
KR102113078B1 (ko) * 2019-07-05 2020-05-20 광주과학기술원 압타머의 선별 방법
CN110791551A (zh) * 2019-09-17 2020-02-14 北京化工大学 一种无载体氯霉素适配体信号放大传感器的建立方法
KR102403628B1 (ko) * 2019-12-03 2022-05-30 주식회사 바이오이즈 시료의 표적분자 집단에 대한 프로파일을 얻는 방법
CN113624724A (zh) * 2020-05-07 2021-11-09 廖世奇 一种适配体分子信标对靶分子的多元检测分析方法
CN111812313B (zh) * 2020-06-22 2021-10-08 北京生物制品研究所有限责任公司 铝佐剂吸附型新型冠状病毒灭活疫苗中抗原的解离方法
US11578320B2 (en) 2021-04-27 2023-02-14 Singular Genomics Systems, Inc. High density sequencing and multiplexed priming
KR20220167781A (ko) * 2021-06-14 2022-12-21 김성천 압타머를 이용하여 시료의 표적 단백질 분자 집단에 대한 프로파일을 얻는 방법

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2763958B2 (ja) 1990-06-11 1998-06-11 ネクスター ファーマスーティカルズ，インコーポレイテッド 核酸リガンド
US6242246B1 (en) 1997-12-15 2001-06-05 Somalogic, Inc. Nucleic acid ligand diagnostic Biochip
CZ20021608A3 (cs) * 1999-11-17 2003-06-18 Roche Diagnostics Gmbh Magnetické skleněné částice, metody jejich přípravy a použití
US7601497B2 (en) * 2000-06-15 2009-10-13 Qiagen Gaithersburg, Inc. Detection of nucleic acids by target-specific hybrid capture method
JP4587954B2 (ja) * 2002-07-24 2010-11-24 バイオ−ラッド・ラボラトリーズ・インコーポレーテッド タンパク質相互作用相違マッピング
ZA200610693B (en) * 2004-05-19 2008-06-25 Vp Holding Llc Optical sensor with layered plasmon structure for enhanced detection of chemical groups by sers
US7699979B2 (en) * 2005-01-07 2010-04-20 Board Of Trustees Of The University Of Arkansas Separation system and efficient capture of contaminants using magnetic nanoparticles
US7285835B2 (en) * 2005-02-24 2007-10-23 Freescale Semiconductor, Inc. Low power magnetoelectronic device structures utilizing enhanced permeability materials
KR20080036595A (ko) * 2005-07-05 2008-04-28 가부시키가이샤 리보믹 면역글로불린 ｇ에 결합하는 핵산과 그 이용법
US20070166740A1 (en) * 2006-01-17 2007-07-19 Somalogic, Incorporated Multiplexed analyses of test samples
US7855054B2 (en) * 2007-01-16 2010-12-21 Somalogic, Inc. Multiplexed analyses of test samples
US7947447B2 (en) * 2007-01-16 2011-05-24 Somalogic, Inc. Method for generating aptamers with improved off-rates
US7964356B2 (en) 2007-01-16 2011-06-21 Somalogic, Inc. Method for generating aptamers with improved off-rates
ES2647587T3 (es) * 2007-07-17 2017-12-22 Somalogic, Inc. Aptámeros con uridinas y/o timidinas sustituidas en la posición 5 con un grupo bencilo
US8291501B2 (en) * 2008-02-08 2012-10-16 Cheng Holdings, Llc Validation of protected intra-system interconnects for digital rights management in electrical computers and digital data processing systems
US20110120487A1 (en) * 2008-05-30 2011-05-26 L'oreal Hair treatment methods and kits
CA2730796C (en) * 2008-07-14 2015-11-03 The University Of Tokyo Aptamer against il-17 and use thereof
CA2758620C (en) * 2009-04-13 2018-10-16 Agriculture And Food Development Authority (Teagasc) Method of producing microbeads
GB0916700D0 (en) * 2009-09-23 2009-11-04 Nanoco Technologies Ltd Semiconductor nanoparticle-based materials

Also Published As

Publication number Publication date
ES2617226T8 (es) 2019-08-27
BR112014030298A2 (pt) 2017-06-27
US20170176422A1 (en) 2017-06-22
CN108614102A (zh) 2018-10-02
CY1118748T1 (el) 2017-07-12
RU2666989C2 (ru) 2018-09-13
EP2859121A4 (en) 2015-12-16
JP2015520385A (ja) 2015-07-16
IN2014KN02647A (es) 2015-05-08
AU2013271401B2 (en) 2018-04-05
HK1204341A1 (en) 2015-11-13
BR112014030298A8 (pt) 2022-03-08
AU2013271401A1 (en) 2014-11-27
US20210239692A1 (en) 2021-08-05
BR112014030298B1 (pt) 2022-09-27
US20150141259A1 (en) 2015-05-21
CA2873099C (en) 2021-06-15
NZ701824A (en) 2017-01-27
ES2617226T3 (es) 2017-06-15
MY170164A (en) 2019-07-09
CN104508150B (zh) 2021-03-12
CA2873099A1 (en) 2013-12-12
CN104508150A (zh) 2015-04-08
RU2014152698A (ru) 2016-08-10
JP6298456B2 (ja) 2018-03-20
EP2859121B1 (en) 2016-11-30
HRP20170296T1 (hr) 2017-04-21
KR102088381B1 (ko) 2020-03-13
MX356413B (es) 2018-05-29
US20180224444A1 (en) 2018-08-09
PH12014502581B1 (en) 2015-01-21
SG10201701361WA (en) 2017-04-27
IL235588A0 (en) 2015-01-29
EP2859121A1 (en) 2015-04-15
ZA201408409B (en) 2017-08-30
WO2013185078A1 (en) 2013-12-12
PH12014502581A1 (en) 2015-01-21
IL235588B (en) 2018-07-31
MX2014014784A (es) 2015-03-19
KR20150030655A (ko) 2015-03-20

Similar Documents

Publication Publication Date Title
SG11201407505XA (en) Aptamer-based multiplexed assays
SG11201908719QA (en) Biomarkers and car t cell therapies with enhanced efficacy
SG11201808552XA (en) T-cell modulatory multimeric polypeptides and methods of use thereof
SG11201403106SA (en) Anti-phf-tau antibodies and their uses
SG11201804086VA (en) Methods and compositions for nucleic acid analysis
SG11201909955XA (en) Formulations of anti-lag3 antibodies and co-formulations of anti-lag3 antibodies and anti-pd-1 antibodies
SG11201803169WA (en) Cellulase variants and polynucleotides encoding same
SG11201804162WA (en) Compositions comprising bacterial strains
SG11201407486PA (en) Compositions and methods for modulating utrn expression
SG11201408780XA (en) Optimization of antibodies that bind lymphocyte activation gene-3 (lag-3), and uses thereof
SG11201810003UA (en) Using programmable dna binding proteins to enhance targeted genome modification
SG11201900746RA (en) Engineered antibodies and other fc-domain containing molecules with enhanced agonism and effector functions
SG11201408385TA (en) Methods of detecting diseases or conditions
SG11201809709UA (en) Aerosol generating systems
SG11201407028WA (en) St2l antagonists and methods of use
SG11201803666WA (en) Single image detection
SG11201408124PA (en) Differentiation of human embryonic stem cells into pancreatic endocrine cells
SG11201804375WA (en) Compositions and methods for internalizing enzymes
SG11201907769XA (en) Cd80 variant immunomodulatory proteins and uses thereof
SG11201407859YA (en) Methods of treating cancer using pd-l1 axis binding antagonists and vegf antagonists
SG11201407483YA (en) Compositions and methods for modulating smn gene family expression
SG11201908056QA (en) Anti-par2 antibodies and uses thereof
SG11201406903SA (en) Cell culture compositions and methods for polypeptide production
SG11201407372UA (en) Nampt inhibitors
SG11201407800SA (en) Selective binding of biological targets to solid phase ureides